
AstraZeneca PLC
AZNNYSEHealthcare● Active
$181.55
$-4.40(-2.37%)
Market Cap$281.6B
P/E Ratio—
52W High$212.71
52W Low$137.22
AstraZeneca PLC(AZN)· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · AZN · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $5.74B | $5.53B | $5.86B | $6.24B | $6.40B |
| Net Receivables | $15.18B | $11.23B | $8.41B | $9.19B | $8.13B |
| Inventory | $6.56B | $5.29B | $5.42B | $4.70B | $8.98B |
| Total Current Assets | $28.72B | $25.83B | $25.05B | $22.59B | $26.24B |
| PP&E Net | $14.70B | $11.65B | $10.50B | $9.45B | $10.17B |
| Goodwill | $21.24B | $21.02B | $20.05B | $19.82B | $20.00B |
| Intangible Assets | $37.85B | $37.18B | $38.09B | $39.31B | $42.39B |
| Total Assets | $114.07B | $104.03B | $101.12B | $96.48B | $105.36B |
| Liabilities | |||||
| Short-Term Debt | $3.19B | $2.16B | $5.13B | $5.22B | $1.57B |
| Accounts Payable | $25.28B | $3.64B | $3.27B | $2.55B | $2.82B |
| Total Current Liabilities | $30.62B | $27.87B | $30.54B | $26.29B | $22.59B |
| Long-Term Debt | $24.71B | $26.51B | $22.36B | $22.96B | $28.13B |
| Total Liabilities | $65.36B | $63.16B | $61.95B | $59.42B | $66.08B |
| Stockholders Equity | |||||
| Retained Earnings | $10.97B | $3.16B | $4.52B | ($0.57B) | $1.71B |
| Total Stockholders Equity | $48.67B | $40.79B | $39.14B | $37.04B | $39.27B |
| Total Liab & Equity(computed) | $114.02B | $103.95B | $101.10B | $96.46B | $105.34B |
| Debt Summary | |||||
| Total Debt | $29.70B | $30.11B | $28.62B | $29.14B | $30.69B |
| Net Debt | $23.99B | $24.63B | $22.78B | $22.98B | $24.36B |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · B
深入了解AstraZeneca PLC
关于AstraZeneca PLC(AZN)资产负债表
AstraZeneca PLC总资产$114.07B,现金及短期投资$5.74B,总负债$65.36B,总债务$29.70B,股东权益$48.67B。
常见问题
AZN · 4 问AstraZeneca PLC总债务$29.70B,净债务$23.99B。
AZN total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10